Scholar Rock Holding Corp. (SRRK)
44.64
-0.86
(-1.89%)
USD |
NASDAQ |
Mar 20, 16:00
44.66
+0.02
(+0.04%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (Quarterly) : 46.45M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 13.23M |
| Stoke Therapeutics, Inc. | 41.29M |
| Zymeworks, Inc. | 31.24M |
| Amylyx Pharmaceuticals, Inc. | 21.10M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |